Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DexCom and CarMax and Encourages Investors to Contact the Firm

Core Points - Class actions have been initiated on behalf of stockholders of DexCom, Inc. and CarMax, Inc. with specific deadlines for investors to petition the court to serve as lead plaintiff [1] DexCom, Inc. (NASDAQ:DXCM) - The class period for DexCom is from January 8, 2024, to September 17, 2025, with a lead plaintiff deadline of December 26, 2025 [6] - The complaint alleges that DexCom made materially false and misleading statements regarding its business and compliance policies, including unauthorized design changes to the G6 and G7 devices that compromised their reliability and posed health risks to users [6] - The lawsuit claims that these misstatements subjected DexCom to increased regulatory scrutiny and potential legal and financial harm [6] CarMax, Inc. (NYSE:KMX) - The class period for CarMax is from June 20, 2025, to September 24, 2025, with a lead plaintiff deadline of January 2, 2026 [6] - The lawsuit alleges that CarMax's defendants overstated growth prospects, attributing earlier growth to temporary factors related to customer behavior influenced by tariff speculation [6] - As a result, the statements made by CarMax's defendants regarding the company's business and operations were deemed materially false and misleading [6]